
    
      The effect of immunochemotherapy in second line treatment of esophageal cancer got a positive
      results in the world. We tried to apply the immunotheray in resectable esophageal cancer and
      have planed this phase III clinical trials. The optimal management of resectable esophageal
      squamous cell carcinomas may have a new chapter in the era of immunotherapy.
    
  